Your session is about to expire
← Back to Search
Telehealth Exercise for Lymphoma Survivors
N/A
Waitlist Available
Led By Kyuwan Lee
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Between 2-5 years after completing anti-cancer therapy with no evidence of disease
Aged 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
Study Summary
This trial is testing whether an at-home exercise program, done with the help of a care provider online, can help improve heart health in lymphoma survivors.
Who is the study for?
This trial is for adults over 18 who've had Hodgkin or non-Hodgkin lymphoma, are 2-5 years post-cancer therapy with no current disease, and have a moderate to high risk of heart issues. They must be able to exercise and not already doing structured workouts more than an hour weekly.Check my eligibility
What is being tested?
The study tests a telehealth exercise program aimed at improving cardiovascular health in lymphoma survivors. Participants will do physical exercises at home guided online by healthcare providers to see if it reduces their risk of heart disease.See study design
What are the potential side effects?
Since the intervention involves exercise, potential side effects may include typical workout-related issues like muscle soreness or strain. However, as this is not a drug trial, severe side effects are less likely compared to medication-based interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I finished my cancer treatment 2-5 years ago and currently show no signs of the disease.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with Hodgkin or non-Hodgkin lymphoma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence to the telehealth exercise intervention
Secondary outcome measures
Effects of an 8-week telehealth exercise intervention
Side effects data
From 2020 Phase 3 trial • 177 Patients • NCT0181707513%
Rash maculo-papular
10%
Skin and subcutaneous tissue disorders - Other, specify
1%
Mucositis oral
1%
Sepsis
1%
Skin ulceration
1%
Urticaria
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (CHG Cleansing Wipe)
Arm II (Control)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (telehealth exercise)Experimental Treatment2 Interventions
Patients participate in telehealth exercise intervention for 30 minutes per day, 3 days a week for 8 weeks.
Group II: Group II (delayed control)Active Control3 Interventions
Patients maintain current levels of physical activity for 8 weeks. Patients may then participate in telehealth exercise intervention for 8 weeks.
Find a Location
Who is running the clinical trial?
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,450 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,657 Total Patients Enrolled
Kyuwan LeePrincipal InvestigatorCity of Hope Medical Center
2 Previous Clinical Trials
54 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't had a heart attack, stroke, or severe chest pain in the last 6 months.I am at a high risk for heart problems.I finished my cancer treatment 2-5 years ago and currently show no signs of the disease.I am pregnant or planning to become pregnant.I am 18 years old or older.I have been diagnosed with Hodgkin or non-Hodgkin lymphoma.
Research Study Groups:
This trial has the following groups:- Group 1: Group I (telehealth exercise)
- Group 2: Group II (delayed control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the participant cap for this medical research endeavor?
"Affirmative. The information on clinicaltrials.gov implies that this trial is now recruiting participants; it was first published on October 20th 2022, and the most recent changes were made on August 30th 2022. Twenty participants are being accepted from a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger